News

Maria Delgado-Lelievre, M.D., right, monitoring patient Anny Stanzione at UHealth's new Hypertension Clinic.

UHealth's New Hypertension Clinic Offers In-Depth Screening for Stroke and Cardiac Risk

09.18.2018

UHealth's new Hypertension Clinic provides in-depth screening and personalized treatment for high blood pressure, the number one risk for heart attack and stroke, the leading causes of death in the United States. “About 45 percent of U.S. adults have high blood pressure, but many don’t realize it until they show up in the emergency room,” said Maria Carolina Delgado-Lelievre, M.D., assistant professor of medicine.

From left, seated, Janet L. Davis, M.D., Julio Adorno Nieves, Santa Nieves and Jorge Adorno Giusti. From left, standing, Audina Berrocal, M.D., Ninel Gregori, M.D., and Byron Lam, M.D.

First U.S. Patient Treated with Nightstar Gene Therapy for X-Linked Retinitis Pigmentosa

09.18.2018

A Puerto Rican patient with X-linked retinitis pigmentosa (XLRP) is hoping to save his vision after an innovative gene therapy procedure at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine. On August 23, Julio Adorno Nieves, 23, became the first U.S. patient to receive new genes for his inherited, blinding condition in a worldwide Nightstar Therapeutics clinical trial.

From left, Edward Abraham, M.D., Alan Zhou, M.D., Wendy Liu, M.D. ’14, Xue Zhong Liu, M.D., seated, Henri R. Ford, M.D., MHA, Li Lin Du, Fred F. Telischi, M.D., MEE.

Dr. Xue Zhong Liu Honored with Marian and Walter Hotchkiss Chair in Otolaryngology

09.14.2018

In honor of his landmark research identifying the genes that cause deafness and its translation to patient care, Xue Zhong Liu, M.D., Ph.D., was recently honored with the Marian and Walter Hotchkiss Chair in Otolaryngology. Dr. Liu — an internationally renowned researcher, author, educator, and otolaryngologist — received the chair August 30 during a ceremony at the Lois Pope LIFE Center.

Sylvester Comprehensive Cancer Center.

Florida Cancer Data System at Sylvester is Again Recognized as One of the Best in the U.S.

09.14.2018

The Florida Cancer Data System, the State of Florida’s legislatively mandated population-based registry located at Sylvester Comprehensive Cancer Center, has received three important distinctions for the quality of its cancer registry data. For the 16th consecutive year, the Florida Cancer Data System (FCDS) has received Gold Certification from the North American Association of Central Cancer Registries.

A patient undergoing radiation therapy.

$2 Million NCI Grant Funds Research to Protect Kidneys from Radiation Therapy

09.13.2018

A cross-departmental team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has received a five-year, $2 million grant from the National Cancer Institute to study ways to protect kidneys from radiation therapy. Specifically, the investigators will be seeking new information about the molecular mechanisms of radiation nephropathy.

Representatives from the Miller School and the Florida Board of Medicine honor Lindsey Finch, center with plaque.

Miller School Student Wins Award from Florida Board of Medicine

09.12.2018

Lindsey Finch, a fourth-year student at the University of Miami Miller School of Medicine, has received the Chair’s Recognition Award from the Florida Board of Medicine. The award recognizes third- and fourth-year students at Florida medical schools who “exemplify the professionalism, moral character, compassion and intellect essential to a future leader of the medical profession.”

Members of the award-winning UHealth Tower Stroke Team, from left, David Lang, D.O., Christina Pacheco, Eldorana Pust, Aliercy Nunez Sanchez, Tara Michelle Cheung, RN, Sebastian Koch, M.D., Michael Greenberg, M.D., Shane Soorus, RN, Julianne Lee Burgos, Betty Hanley, Cathy Rosenberg, MSN, ARNP-BC, Amanda Demane, SLP, and Miguel Garcia.

UHealth Tower Receives Top Award for Care of Stroke Patients

09.12.2018

UHealth Tower, a unit of University of Miami Hospital and Clinics, has received the American Heart Association/American Stroke Association’s Get With The Guidelines-Stroke Gold Plus Quality Achievement Award. The award recognizes the hospital’s commitment to ensuring that stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.

Jeffrey Brosco, M.D., Ph.D., with FCAAP President Madeline Joseph, M.D.

Dr. Jeffrey Brosco Receives Award for Service to Florida’s Children

09.11.2018

The Florida Chapter of the American Academy of Pediatrics awarded Jeffrey P. Brosco, M.D. Ph.D., professor of clinical pediatrics and associate director of the Mailman Center for Child Development at the University of Miami Miller School of Medicine, with the 2018 Audrey Lincourt Schiebler, FAAP, and Gerold Schiebler, M.D., FAAP 2018 Advocacy Award.

A phase III clinical trial is beginning for Arimoclomol, a heat shock protein-based therapy that shows promise for the treatment of ALS.

Phase III Trial of Arimoclomol for ALS Starts at the University of Miami Health System

09.11.2018

Physician-researchers with the University of Miami Health System and the Miller School Medicine recently enrolled the first patient in a phase III trial of the drug Arimoclomol for the treatment of amyotrophic lateral sclerosis. The randomized patient received the drug on August 10. ALS, also known as Lou Gehrig’s disease, is a rapidly progressive, fatal disease that attacks the nerve cells that control voluntary muscles.